IP Library Granted Patent US 9,532,942
Granted Patent B2
US 9,532,942 · App. 14/864,729 · Granted Jan 3, 2017

Apparatus and method of stimulating elevation of glutathione levels in a subject

Inventor: David G. Schmidt (Poway, CA)
Assignee: LifeWave, Inc.
A61K9/0014A61K31/198A61K38/063A61N2/02A61N2005/0645A61N2005/0659A61N2005/0661
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,532,942
App. No.
14/864,729
Granted
Jan 3, 2017
Kind
B2
Abstract

An apparatus configured to provide a beneficial biological effect for a subject, and/or a method of treating the subject using the apparatus. The apparatus may be configured to trigger and maintain the elevation of Glutathione levels within the subject. The apparatus may rely on a non-invasive mechanism to elevate Glutathione levels in the subject. The apparatus may not require a traditional power source such as a battery or wall plug in order to be effective in elevating Glutathione levels in the subject. To trigger and maintain the elevation of Glutathione levels within the subject, the apparatus may transmit communication to the body of the subject that results in increased levels of Glutathione within the subject.

Claims (18)

1. A method of treating a subject, the method comprising:

elevating Glutathione levels by a therapeutically effective amount by affixing an apparatus to the subject such that the apparatus remains at or near the skin of the subject for a prolonged period of time, wherein the apparatus comprises:

one or more substrates;

a chemical mixture disposed on or about the one or more substrates, the chemical mixture including one or more natural amino acids, wherein if the one or more substrates and the chemical mixture are brought proximate to the subject; and

an enclosure that surrounds the one or more substrates and the chemical mixture and is at least temporarily impermeable to the chemical mixture,

wherein the proximity of the one or more substrates and the chemical mixture to the subject while the enclosure is impermeable to the chemical mixture trigger and maintain an increase in Glutathione levels in the body of the subject.

2. The method of claim 1 , wherein the chemical mixture comprises Glutathione.

3. The method of claim 1 , wherein the chemical mixture produces a photobiomodulation effect.

4. A method of treating a subject, the method comprising:

treating a subject suffering from a Glutathione mediated condition including one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, exposure to a chemical weapon, an effect of mercury exposure, or diabetes by elevating Glutathione levels in the subject to a therapeutically effective level by affixing an apparatus to the subject such that the apparatus remains at or near the skin of the subject for a prolonged period of time, wherein the apparatus comprises:

one or more substrates;

a chemical mixture disposed on or about the one or more substrates, the chemical mixture including one or more natural amino acids, wherein if the one or more substrates and the chemical mixture are brought proximate to the subject; and

an enclosure that surrounds the one or more substrates and the chemical mixture and is at least temporarily impermeable to the chemical mixture,

wherein the proximity of the one or more substrates and the chemical mixture to the subject while the enclosure is impermeable to the chemical mixture trigger and maintain an increase in Glutathione levels in the body of the subject.

5. The method of claim 4 , wherein the chemical mixture comprises Glutathione.

6. The method of claim 5 , wherein treating the subject suffering from a Glutathione mediated condition including one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes comprises treating the subject for side effects of another treatment administered to the subject for one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes.

7. The method of claim 6 , wherein treating the subject for one or more of a pulmonary disease, a degenerative brain condition, a viral infection, a burn injury, acute pancreatitis, an immune dysfunction, or diabetes comprises elevating the Glutathione levels within the body of the subject.

8. The method of claim 4 , wherein the chemical mixture produces a photobiomodulation effect.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2018
From: LIFEWAVE, INC.
To: SOLETLUNA HOLDINGS, INC.
Reel/Frame 045799/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2015
From: SCHMIDT, DAVID
To: LIFEWAVE PRODUCTS LLC
Reel/Frame 036654/0877 →
MERGER Recorded Sep 25, 2015
From: LIFEWAVE PRODUCTS LLC
To: LIFEWAVE CONSOLIDATION CORPORATION
Reel/Frame 036655/0034 →
CHANGE OF NAME Recorded Sep 25, 2015
From: LIFEWAVE CONSOLIDATION CORPORATION
To: LIFEWAVE, INC.
Reel/Frame 036689/0334 →
Continuity (3)
Continuation 14101046 · Dec 9, 2013
Division 12121674 · May 15, 2008
Related Publication 20160166502A1 · Jun 16, 2016